Ann: Annual Report to Shareholders, page-16

How about to see a news like this after the Q1 announcement



Avita medical (RECELL ) reported worse-than-expected first-quarter earnings and revenue late 12 Monday.Investors appeared not to care, sending RECELL shares jumping 30% after Chief Executive Jim Corbett signaled "more affordable" new RECELL GO MINI models are on the way following the launch of RECELL GO.Jim also predicted 2025 revenue would be a history, stressing Avita medical focus on completing 340 accounts this year and targeting another 800 highly soft tissue repair accounts in total following years.Moreover number of interested parties are approached to takeover and not considered due to our huge market expectations.Also the cash burn was minimal this quarter due to majorly of our spending for tone study, RECELL GO house test, etc already factored in Q4 2023.Our warehouse expansion planned only in Q3 2024 and we will have enough revenue to manage after RECELL GO launch.Majorly of our new staffs are part time and they are training to use only RECELL GO device which cost far lesser than normal autonomous device.